Detalhe da pesquisa
1.
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in KEAP1 mutant lung cancer.
Sci Adv
; 10(13): eadm9859, 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38536921
2.
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in KEAP1 mutant lung cancer.
bioRxiv
; 2023 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37425844